A carregar...
Lay media reporting of rosiglitazone risk: extent, messaging and quality of reporting
BACKGROUND: A meta-analysis suggested the use of rosiglitazone was associated with an increased risk for cardiovascular (CV) events. Rosiglitazone remained available for use as more definitive safety trials were ongoing. This issue was reported in the lay media. OBJECTIVE: To review lay media articl...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2727509/ https://ncbi.nlm.nih.gov/pubmed/19630978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-8-40 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|